BioAge Labs BIOA
NASDAQ BIOA
$7.11 -0.03 (-0.42%)
As of: Sep 30, 2026 · 12:45 PM EDT

BioAge Labs, Inc. (BIOA) Common Equity (2023 - 2026)

Updated

BioAge Labs' Common Equity came in at $374.91 million for Q2 2026, up 27.2% from $294.78 million a year earlier but down 1.1% from the prior quarter.

Analysis

BioAge Labs, Inc. (BIOA) Common Equity (2023 - 2026) Analysis & Trends

At the end of FY2025, BioAge Labs' Common Equity was $272.05 million, down 15.8% from FY2024.

  • Going back by year, Common Equity was $323.13 million in FY2024 and -$173.4 million in FY2023.
  • The five-year range for quarterly Common Equity is -$197.13 million (Q2 2024) to $379.12 million (Q1 2026).
  • Year-over-year, Common Equity increased in two of the last four quarters, with growth averaging 5.2%.
  • Business Quant data shows BIOA's Common Equity at $379.12 million (Q1 2026), $272.05 million (Q4 2025) and $277.46 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 374.91 Mn
Mar 31, 2026 379.12 Mn
Dec 31, 2025 272.05 Mn
Sep 30, 2025 277.46 Mn
Jun 30, 2025 294.78 Mn
Mar 31, 2025 313.17 Mn
Dec 31, 2024 323.13 Mn
Sep 30, 2024 313.75 Mn
Jun 30, 2024 -197.13 Mn
Mar 31, 2024 -185.51 Mn
Dec 31, 2023 -173.40 Mn
Sep 30, 2023 -153.14 Mn
API Access

BioAge Labs, Inc. Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=BIOA&period=max&api_key=YOUR_API_KEY